Advertisement

Virchows Archiv

, Volume 448, Issue 3, pp 311–318 | Cite as

An adiponectin receptor, T-cadherin, was selectively expressed in intratumoral capillary endothelial cells in hepatocellular carcinoma: possible cross talk between T-cadherin and FGF-2 pathways

  • Yoshihiro Adachi
  • Tamotsu TakeuchiEmail author
  • Hiroshi Sonobe
  • Yuji Ohtsuki
Original Article

Abstract

T-cadherin is a unique receptor of adiponectin, which plays a critical role in various angiogenesis. In the present study, T-cadherin expression in tumor vessels of hepatocellular carcinoma (HCC) and, subsequently, the molecular mechanism, which induced T-cadherin expression in sinusoidal endothelial cells were investigated. Sinusoidal endothelium in nontumorous liver, chronic hepatitis, or liver cirrhosis expressed little or no T-cadherin. By contrast, T-cadherin was found in intratumoral capillary endothelial cells of 34 out of 63 HCC specimens. In positive cases, focal T-cadherin expression was found in well-differentiated HCC, whereas diffuse and intense T-cadherin expression was observed in poorly differentiated HCC specimens. T-cadherin was much expressed in intratumoral capillary endothelial cells in a less differentiated HCC region than that in a well-differentiated region in five specimens, in which various differentiated HCC components were coexistent. In a double-cell chamber assay, fibroblast growth factor-2 appeared to have a critical role to induce T-cadherin in cultured liver sinusoidal endothelial cells. The present finding indicated that T-cadherin was selectively expressed in intratumoral capillary endothelial cells of many HCCs, increasingly expressed as tumor progression, and T-cadherin may have a positive role in angiogenesis of HCC. In addition, cross talk between the signal pathways mediated by fibroblast growth factor-2 and adiponectin was suggested.

Keywords

T-cadherin Adiponectin Hepatocellular carcinoma Neovascularization 

Notes

Acknowledgements

We thank Mr. Yamaguchi, Takuya, Ms. Nakamura, Naoyo (Department of Pathology, Kochi Medical School), and Ms. Matumura, Rumi (Division of Molecular Biology, Kochi Medical School) for skillful technique. This study was supported by grants from the Ministry of Education of Japan (KAKEN 12670165, 13670177, and 17590270) and the Medical Research Fund of Kochi Medical School.

References

  1. 1.
    Asada N, Tanaka Y, Hayashido Y, Toratani S, Kan M, Kitamoto M, Nakanishi T, Kajiyama G, Chayama K, Okamoto T (2003) Expression of fibroblast growth factor receptor genes in human hepatoma-derived cell lines. In Vitro Cell Dev Biol Anim 39:321–328CrossRefPubMedGoogle Scholar
  2. 2.
    Bråkenhielm B, Veitonmäki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Fukuhashi T, Cao Y (2004) Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A 101:2476–2481CrossRefPubMedGoogle Scholar
  3. 3.
    Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257CrossRefPubMedGoogle Scholar
  4. 4.
    Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, Van De Rijn M, Botstein D, Brown PO (2002) Gene expression patterns in human liver cancers. Mol Biol Cell 13:1929–1939CrossRefPubMedGoogle Scholar
  5. 5.
    Edmonson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 among 489,000 necropsies. Cancer (Phila), 7:462–503CrossRefGoogle Scholar
  6. 6.
    Edwards S, Lalor PF, Nash GB, Rainger GE, Adams DH (2005) Lymphocyte traffic through sinusoidal endothelial cells is regulated by hepatocytes. Hepatology 41:451–459CrossRefPubMedGoogle Scholar
  7. 7.
    Gibson JB, Sobin LH (1978) Histological typing of tumors of the liver, biliary tract and pancreas. In: International Histological Classification of Tumors. World Health Organization, Geneva 19–25Google Scholar
  8. 8.
    Goldstein BJ, Scalia R (2004) Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89:2563–2568CrossRefPubMedGoogle Scholar
  9. 9.
    Huang ZY, Wu Y, Hedrick N, Gutmann DH (2003) T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression. Mol Cell Biol 23:566–578CrossRefPubMedGoogle Scholar
  10. 10.
    Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF (2004) T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A 101:10308–10313CrossRefPubMedGoogle Scholar
  11. 11.
    Ivanov D, Philippova M, Allenspach R, Erne P, Resink T (2004) T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells. Cardiovasc Res 64:132–143CrossRefPubMedGoogle Scholar
  12. 12.
    Jin-no K, Tanimizu M, Hyodo I, Kurimoto F, Yamashita T (1997) Plasma level of basic fibroblast growth factor increases with progression of chronic liver disease. J Gastroenterol 32:119–121CrossRefPubMedGoogle Scholar
  13. 13.
    Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y (2004) Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94:27–31CrossRefGoogle Scholar
  14. 14.
    Lee SW (1996) H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 2:776–782CrossRefPubMedGoogle Scholar
  15. 15.
    Li X, Massa PE, Hanidu A, Peet GW, Aro P, Savitt A, Mische S, Li J, Marcu KB (2002) IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program. J Biol Chem 277:45129–45140CrossRefPubMedGoogle Scholar
  16. 16.
    Maret A, Galy B, Arnaud E, Bayard F, Prats H (1995) Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line. Cancer Res 55:5075–5079PubMedGoogle Scholar
  17. 17.
    Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zochbauer-Muller S, Farinas AJ, Vakar-Lopez F, Minna JD, Sagalowsky A, Czerniak B, Gazdar AF (2001) Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 61:8659–8663PubMedGoogle Scholar
  18. 18.
    Mise M, Arii S, Higashituji H, Furutani M, Niwano M, Harada T, Ishigami S, Toda Y, Nakayama H, Fukumoto M, Fujita J, Imamura M (1996) Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 23:455–464PubMedCrossRefGoogle Scholar
  19. 19.
    Motoo Y, Sawabu N, Yamaguchi Y, Terada T, Nakanuma Y (1993) Sinusoidal capillarization of human HCC: possible promotion by fibroblast growth factor. Oncology 50:270–274PubMedCrossRefGoogle Scholar
  20. 20.
    Mouta Carreira C, Nasser SM, di Tomaso E, Padera TP, Boucher Y, Tomarev SI, Jain RK (2001) LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 61:8079–8084PubMedGoogle Scholar
  21. 21.
    Nagafuchi A, Takeichi M (1988) Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J 7:3679–3684PubMedGoogle Scholar
  22. 22.
    Nakamura S, Muro H, Suzuki S, Sakaguchi T, Konno H, Baba S, Syed AS (1997) Immunohistochemical studies on endothelial cell phenotype in hepatocellular carcinoma. Hepatology 26:407–415CrossRefPubMedGoogle Scholar
  23. 23.
    El-Assal ON, Yamanoi A, Ono T, Kohno H, Nagasue N (2001) The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in HCC. Clin Cancer Res 7:1299–1305PubMedGoogle Scholar
  24. 24.
    Oshima RG, Lesperance J, Munoz V, Hebbard L, Ranscht B, Sharan N, Muller WJ, Hauser CA, Cardiff RD (2004) Angiogenic acceleration of Neu induced mammary tumor progression and metastasis. Cancer Res 64:169–179CrossRefPubMedGoogle Scholar
  25. 25.
    Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K (2004) Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279:1304–1309CrossRefPubMedGoogle Scholar
  26. 26.
    Ranscht B, Dours-Zimmermann MT (1991) T-cadherin, a novel cadherin cell adhesion molecule in the nervous system, lacks the conserved cytoplasmic region. Neuron 7:391–402CrossRefPubMedGoogle Scholar
  27. 27.
    Riou P, Saffroy R, Comoy J, Gross-Goupil M, Thiery JP, Emile JF, Azoulay D, Piatier-Tonneau D, Lemoine A, Debuire B (2002) Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma. Clin Cancer Res 8:3178–3186PubMedGoogle Scholar
  28. 28.
    Roman-Gomez J, Castillejo JA, Jimenez A, Cervantes F, Boque C, Hermosin L, Leon A, Granena A, Colomer D, Heiniger A, Torres A (2003) Cadherin-13, a mediator of calcium-dependent cell–cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa. J Clin Oncol 21:1429–1472CrossRefPubMedGoogle Scholar
  29. 29.
    Sakai M, Hibi K, Koshikawa K, Inoue S, Takeda S, Kaneko T, Nakao A (2004) Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer. Cancer Sci 95:588–591CrossRefPubMedGoogle Scholar
  30. 30.
    Sakamoto M, Ino Y, Fujii T, Hirohashi S (1993) Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma. Jpn J Clin Oncol 23:98–104PubMedGoogle Scholar
  31. 31.
    Sato M, Mori Y, Sakurada A, Fujimura S, Horii A (1998) The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet 103:96–101. Erratum in: Hum Genet (1998) 103:532CrossRefPubMedGoogle Scholar
  32. 32.
    Takeuchi T, Kobayashi M, Moriki T, Miyoshi I (1988) Application of a monoclonal antibody for the detection of Trichosporon beigelii in paraffin-embedded tissue sections. J Pathol 15:23–27CrossRefGoogle Scholar
  33. 33.
    Takeuchi T, Misaki A, Chen BK, Ohtsuki Y (1999) H-cadherin expression in breast cancer. Histopathology 35:87–88CrossRefPubMedGoogle Scholar
  34. 34.
    Takeuchi T, Misaki A, Liang S-B, Tachibana A, Hayashi N, Sonobe H, Ohtsuki Y (2000) Expression of T-cadherin (CDH13, H-cadherin) in human brain and its characteristics as a negative growth regulator of EGF in neuroblastoma cells. J Neurochem 74:1489–1497CrossRefPubMedGoogle Scholar
  35. 35.
    Takeuchi T, Ohtsuki Y (2001) Recent progress of T-cadherin (CDH13, H-cadherin) research. Histol Histopathol 16:1287–1293PubMedGoogle Scholar
  36. 36.
    Takeuchi T, Liang SB, Matsuyoshi N, Zhou S, Miyachi Y, Sonobe H, Ohtsuki Y (2002a) Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma. Lab Invest 82:1023–1029PubMedGoogle Scholar
  37. 37.
    Takeuchi T, Liang SB, Ohtsuki Y (2002b) Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin. Mol Carcinog 35:173–179CrossRefPubMedGoogle Scholar
  38. 38.
    Salomon D, Ayalon O, Patel-King R, Hynes RO, Geiger B (1992) Extrajunctional distribution of N-cadherin in cultured human endothelial cells. J Cell Sci 102:7–17PubMedGoogle Scholar
  39. 39.
    Tsao TS, Murrey HE, Hug C, Lee DH, Lodish HF (2002) Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 277:29359–29362CrossRefPubMedGoogle Scholar
  40. 40.
    Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF (2001) Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 61:4556–4560PubMedGoogle Scholar
  41. 41.
    Toyooka S, Toyooka KO, Harada K, Miyajima K, Makarla P, Sathyanarayana UG, Yin J, Sato F, Shivapurkar N, Meltzer SJ, Gazdar AF (2002) Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 62:3382–3386PubMedGoogle Scholar
  42. 42.
    Wyder L, Vitaliti A, Schneider H, Hebbard LW, Moritz DR, Wittmer M, Ajimo M, Klemenz R (2000) Increased expression of H/T-cadherin in tumor penetrating blood vessels. Cancer Res 60:4682–4688PubMedGoogle Scholar
  43. 43.
    Zhou S, Matsuyoshi N, Liang SB, Takeuchi T, Ohtsuki Y, Miyachi Y (2002) Expression of T-cadherin in basal keratinocytes of skin. J Invest Dermatol 118:1080–1084CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Yoshihiro Adachi
    • 1
  • Tamotsu Takeuchi
    • 1
    Email author
  • Hiroshi Sonobe
    • 2
  • Yuji Ohtsuki
    • 1
  1. 1.Department of PathologyKochi Medical SchoolKochiJapan
  2. 2.Department of Laboratory Medicine and PathologyNational Hospital Organization Fukuyama Medical CenterHiroshimaJapan

Personalised recommendations